ICD 10 Coding Alert

Oncology:

D70.1 Will Offer a Chemotherapy-Specific Neutropenia Option

Start thinking in terms of 'agranulocytosis.'Once ICD-10-CM replaces ICD-9-CM in 2014, not only will you have more options to report neutropenia, but you'll also need to be ready to report every character of adverse effect code T45.1X5-. Here are the details.ICD-9-CM Code288.03, Drug induced neutropeniaICD-10-CM CodesD70.1, Agranulocytosis secondary to cancer chemotherapy70.2, Other drug-induced agranulocytosis Diagnosis: Drug-induced neutropenia refers to an abnormally low count of neutrophils (white blood cells) caused by a drug the patient is taking. Agranulocytosis refers to a severe type of neutropenia.ICD-9-CM coding rules: An instruction with 288.03 indicates you should use an additional E code to identify the drug that resulted in neutropenia. You also should use an additional code for any associated fever (780.61) or mucositis (478.11, 528.00-528.09, 538, or 616.81). Code 288.03 is appropriate for documentation of decreased absolute neutrophil count (ANC), but ICD-9-CM lists three diagnoses that are excluded from 288.03: neutropenic splenomegaly (289.53), [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

ICD 10 Coding Alert

View All